A preliminary study utilizing ultrasound to assess changes in cervical lymph nodes, located in the neck, in patients with dementia.
- Conditions
- Mental and behavioural disorders
- Registration Number
- KCT0009484
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
From the date of IRB approval until December 31, 2024, Seoul Asan Hospital is recruiting participants aged 50 and above who have been diagnosed with progressive dementia with a GDS score of 4 or higher. Participants must meet the following criteria:
Have never been diagnosed with dementia or mild cognitive impairment.
Have no other physical or mental disorders.
Have no history of diagnosed lymph node diseases.
These criteria are for recruiting a control group.
Patients with Dementia with Lewy Bodies (DLB) are excluded. Those with severe renal function impairment (GFR 30 or below) or concomitant liver failure are also excluded. Participants who do not wish to participate or refuse to sign the consent form are excluded. Additionally, participants may be excluded if, at the discretion of the clinical trial investigator, it is deemed impractical to conduct the clinical trial due to reasons other than those mentioned above.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method